Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands - Concepedia

Concepedia

Publication | Open Access

Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands

DOI Full Paper Access

14

Citations

25

References

2016

Year

Jelena Stevanović, Lisa A. de Jong, Bregt S Kappelhoff, Evgeni Dvortsin, Maarten Voorhaar, Maarten J. Postma

Abstract

From a societal perspective, dabigatran is likely to be a cost-effective or even cost-saving strategy for treatment and secondary prevention of VTE compared to VKAs in the Netherlands.

References

	Year	Citations

Page 1